Back | Next |
home / stock / ecyt / ecyt message board
Subject | By | Source | When |
---|---|---|---|
...up | robertus | investorshub | 12/04/2017 3:19:18 PM |
Something is brewing | robertus | investorshub | 11/30/2017 8:03:22 PM |
http://stockcharts.com/h-sc/ui?s=$ECYT&p=D&yr=0&mn=2&dy=0&id=p12731932724 | robertus | investorshub | 11/17/2017 6:02:15 PM |
Nope...shorting limited here as shares held very tightly | Deuces | investorshub | 11/17/2017 5:01:02 PM |
No pullback today | robertus | investorshub | 11/17/2017 4:59:31 PM |
$6 around the corner | Deuces | investorshub | 11/16/2017 6:25:27 PM |
Yes, very low volume | robertus | investorshub | 11/15/2017 6:08:49 PM |
Shares have become tight thats for sure | Deuces | investorshub | 11/15/2017 3:54:34 PM |
O, good then, there were many shorts that | robertus | investorshub | 11/15/2017 3:52:06 PM |
I never short. Im long this position. | Deuces | investorshub | 11/15/2017 3:49:53 PM |
Have you covered already? Looks like squezze soon | robertus | investorshub | 11/15/2017 3:44:07 PM |
Being shorted due to a negative Seeking Alpha | Deuces | investorshub | 11/14/2017 12:17:46 AM |
Good if close above resistance level at 5,16 | robertus | investorshub | 11/09/2017 8:14:19 PM |
$ECYT 5.3 +10% looks who is back. Think | PAC | investorshub | 11/09/2017 7:34:34 PM |
Nice day today!!! Im thinking we see | Deuces | investorshub | 11/09/2017 4:10:09 PM |
Very low volume these days. I believe a | robertus | investorshub | 11/08/2017 6:42:18 PM |
Im watching. Own quite a few. | Deuces | investorshub | 11/01/2017 8:43:20 PM |
Nice to see someone alive here. I believe if | robertus | investorshub | 11/01/2017 6:39:02 PM |
$ECYT 4.75 think this not done. Could see | PAC | investorshub | 11/01/2017 6:17:23 PM |
Cabindweller: dont give up on endocyte...the day is almost here....their prostrate trial will do wel | Cabindweller | investorshangout | 10/24/2017 2:33:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Entered into agreement and plan of merger with Novartis AG for $2.1Billion WEST LAFAYETTE, Ind., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics...
WEST LAFAYETTE, Ind., Sept. 27, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company’s management team will present at two upcoming investor conferences ...